Ocugen (OCGN) Common Equity (2014 - 2026)

Ocugen (OCGN) has 13 years of Common Equity data on file, last reported at $5.8 million in Q1 2026.

• Quarterly Common Equity fell 63.52% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (down 63.52% YoY) and the FY2025 annual result came in at -$12.2 million, down 141.06% from the prior year.
• Common Equity improved to $5.8 million in Q1 2026, from -$12.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $125.5 million in Q1 2022 to a low of -$12.2 million in Q4 2025.
• A 5-year average of $43.5 million and a median of $40.6 million in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity jumped 169.99% — and 2025, when it plunged 141.06%.
• Tracing OCGN's Common Equity over 5 years: stood at $74.0 million in 2022, then plunged by 45.17% to $40.6 million in 2023, then declined by 26.95% to $29.6 million in 2024, then sank by 141.06% to -$12.2 million in 2025, then surged by 147.71% to $5.8 million in 2026.
• The last three Common Equity figures came in at $5.8 million (Q1 2026), -$12.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.